Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?

Journal of Clinical Investigation

Volumn 111, Issue 2, 2003, Pages 163-169

  Ischiropoulos, Harry ^a,c   Beckman, Joseph S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; COPPER; DOPAMINE; FERRITIN; FLAVOPROTEIN; IRON; OXIDIZING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; GENE MUTATION; HUMAN; IRON STORAGE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NITRATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MODIFICATION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; HUMANS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PARKINSON DISEASE; SUPEROXIDE DISMUTASE; SYNUCLEINS;

EID: 0037237927     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317638     Document Type: Review

References (76)

1. Lyras, L., et al. 1998. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71:302-312.
2. Hensley, K., et al. 1998. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:8126-8132.
3. Pratico, D., et al. 2000. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol. 48:809-812.
4. Giasson, B.I., et al. 2000. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290:985-989.
5. Beal, M.F., et al. 1997. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:644-654.
6. Bagasra, O., et al. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:12041-12045.
7. Browne, S.E., Ferrante, R.J., and Beal, M.F. 1999. Oxidative stress in Huntington's disease. Brain Pathol. 9:147-163.
8. Moskovitz, J., et al. 2001. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA. 98:12920-12925.
9. Gabbita, S.P., Aksenov, M.Y., Lovell, M.A., and Markesbery, W.R. 1999. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73:1660-1666.
10. De Boer, J., et al. 2002. Premature aging in mice deficient in DNA repair and transcription. Science. 296:1276-1279.
11. Troy, C.M., Derossi, D., Prochiantz, A., Greene, L.A., and Shelanski, M.L. 1996. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16:253-261.
12. Kondo, T., et al. 1997. Reduction of Cu, Zn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17:4180-4189.
13. Lebovitz, R.M., et al. 1996. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA. 93:9782-9787.
14. Zhang, J., Graham, D.G., Montine, T.J., and Ho, Y.S. 2000. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in Cu, Zn-superoxide dismutase or glutathione peroxidase. J. Neuropathol. Exp. Neurol. 59:53-61.
15. Yokota, T., et al. 2001. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. USA. 98:15185-15190.
16. Sano, M., et al. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336:1216-1222.
17. Desnuelle, C., Dib, M., Garrel, C., and Favier, A. 2001. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2:9-18.
18. Huang, J., et al. 2001. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl. Acad. Sci. USA. 98:11720-11724.
19. Sotiriou, S., et al. 2002. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into brain and for perinatal survival. Nat. Med. 8:514-517.
20. Huang, X., et al. 1999. Cu(II) potentiation of Alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274:37111-37116.
21. Takahashi, M., et al. 2000. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron. 28:461-473.
22. Cherny, R.A., et al. 2001. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:665-676.
23. Chan, P.H., Yang, G.Y., Chen, S.F., Carlson, E., and Epstein, C.J. 1991. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing Cu, Zn-superoxide dismutase. Ann. Neurol. 29:482-486.
24. Przedborski, S., et al. 1992. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1658-1667.
25. Nakao, N., et al. 1995. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:226-231.
26. Keller, J.N., et al. 1998. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:687-697.
27. Dawson, V.L., Kizushi, V.M., Huang, P.L., Snyder, S.H., and Dawson, T.M. 1996. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:2479-2487.
28. Pineda, J.A., et al. 2001. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J. Neurotrauma. 18:625-634.
29. Pong, K., Doctrow, S.R., and Baudry, M. 2000. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Brain Res. 881:182-189.
30. Orr, W.C., and Sohal, R.S. 1994. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263:1128-1130.
31. Melov, S., et al. 2000. Extension of life-span with superoxide dismutase/catalase mimetics. Science. 289:1567-1569.
32. Parkes, T.L., et al. 1998. Extension of Drosophila lifespan by overexpression of human SOD1 in motor neurons. Nat. Genet. 19:171-174.
33. Swerdlow, R.H., et al. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40:663-671.
34. Davis, R.E., et al. 1997. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:4526-4531.
35. Tammariello, S.P., Quinn, M.T., and Estus, S. 2000. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J. Neurosci. 20:RC53.
36. Beckman, J.S. 1994. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. In The neurobiology of NO_and_OH. C.C. Chiueh, D.L. Gilbert, and C.A. Colton, editors. New York Academy of Sciences. New York, New York, USA. 69-75.
37. Harrison, J.E., and Schultz, J. 1976. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374.
38. Brennan, M.L., et al. 2002. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and meyloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 277:17415-17427.
39. Hantraye, P., et al. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1017-1021.
40. Eliasson, M.J., et al. 1999. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19:5910-5918.
41. Ayata, C., et al. 1997. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J. Neurosci. 17:6908-6917.
42. Przedborski, S., et al. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:4565-4571.
43. Liberatore, G.T., et al. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5:1403-1409.
44. Vodovotz, Y., et al. 1996. Inducible nitric oxide synthase in tangle-beating neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1425-1433.
45. Kean, R.B., Spitsin, S.V., Mikheeva, T., Scott, G.S., and Hooper, D.C. 2000. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J. Immunol. 165:6511-6518.
46. Yu, Z.F., Bruce-Keller, A.J., Goodman, Y., and Mattson, M.P. 1998. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 53:613-625.
47. Wu, D.C., et al. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22:1763-1771.
48. Zhu, S., et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:74-78.
49. Xie, Z., et al. 2002. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22:3484-3492.
50. Betarbet, R., et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306.
51. Manning-Bog, A.B., et al. 2002. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. 277:1641-1644.
52. Lee, H.J., Shin, S.Y., Choi, C., Lee, Y.H., and Lee, S.J. 2002. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem. 277:5411-5417.
53. Paxinou, E., et al. 2001. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21:8053-8061.
54. Polymeropoulos, M.H., et al. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:2045-2047.
55. Spillantini, M.G., et al. 1997. Alpha-synuclein in Lewy bodies. Nature. 388:839-840.
56. Hashimoto, M., et al. 1999. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport. 10:717-721.
57. Ostrerova-Golts, N., et al. 2000. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20:6048-6054.
58. Souza, J.M., Giasson, B.I., Chen, Q., Lee, V.M., and Ischiropoulos, H. 2000. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275:18344-18349.
59. Souza, J.M., Daikhin, E., Yudkoff, M., Raman, C.S., and Ischiropoulos, H. 1999. Factors determining the selectivity of protein tyrosine nitration. Arch. Biochem. Biophys. 371:169-178.
60. Tabrizi, S.J., et al. 2000. Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9:2683-2689.
61. Xu, J., et al. 2002. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8:600-606.
62. Hastings, T.G., Lewis, D.A., and Zigmond, M.J. 1996. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA. 93:1956-1961.
63. Lee, F.J.S., Liu, F., Pristupa, Z.B., and Niznik, H.B. 2001. Direct binding and functional coupling of a-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 15:916-926.
64. Perez, R.G., et al. 2002. A role for a-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22:3090-3099.
65. Lotharius, J., and O'Malley, K.L. 2000. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275:38581-38588.
66. Abeliovich, A., et al. 2000. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 25:239-252.
67. Conway, K.A., Rochet, J.C., Bieganski, R.M., and Lansbury, P.T., Jr. 2001. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 294:1346-1349.
68. Gurney, M.E., et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1772-1775.
69. Williamson, T.L., et al. 2000. Toxicity of ALS-linked SOD1 mutants. Science. 288:399.
70. Crow, J.P., et al. 1997. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1936-1944.
71. Estévez, A.G., et al. 1999. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 286:2498-2500.
72. Estévez, A.G., et al. 1998. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18:923-931.
73. Subramaniam, J.R., et al. 2002. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5:301-307.
74. Cassina, P., et al. 2002. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J. Neurosci. Res. 67:21-29.
75. Curtis, A.R., et al. 2001. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28:350-354.
76. Zhou, B., et al. 2001. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28:345-349.